Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Madeleine Pettersson Bergstrand"'
Autor:
Michel Arvidsson, Johan Franck, Gerd Ackehed, Madeleine Pettersson Bergstrand, Lena Ekström, Staffan Rosenborg, Marja‐Liisa Dahl
Publikováno v:
Basicclinical pharmacologytoxicology. 130(4)
Scarce data are available on methylphenidate (MPH) plasma concentrations reached after doses higher than 180 mg. The interindividual and intraindividual variability in the exposure of MPH and ritalinic acid (RA) enantiomers was examined in 28 patient
Publikováno v:
Clinical Mass Spectrometry. 10:25-32
Hundreds of new psychoactive substances (NPS) covering most drugs-of-abuse classes have been introduced to the recreational drug market in recent years. One class of NPS drugs that has become more common recently is “designer” benzodiazepines. Du
Autor:
Simon D. Brandt, Lilian H.J. Richter, Lea Wagmann, Tobias Kehl, Madeleine Pettersson Bergstrand, Hans H. Maurer, Franziska Wack, Alexander Stratford, Markus R. Meyer
Publikováno v:
Analytical and bioanalytical chemistry. 411(19)
The market of new psychoactive substances (NPS) is characterized by a high turnover and thus provides several challenges for analytical toxicology. The analysis of urine samples often requires detailed knowledge about metabolism given that parent com
Publikováno v:
Clinical toxicology (Philadelphia, Pa.). 57(3)
In recent years, many unclassified benzodiazepines (BZD) have appeared through online sale as new psychoactive substances (NPS). This study describes bioanalytical and clinical data related to intoxications involving NPS BZD ("designer BZD") in the S
Publikováno v:
Drug Testing and Analysis. 9:640-645
The emerging new psychoactive substances made available for recreational drug use have recently started to include designer benzodiazepines. As a consequence, the routine immunoassay drug testing for benzodiazepines may become less effective, due to
Autor:
Markus R. Meyer, Hans H. Maurer, Lea Wagmann, Madeleine Pettersson Bergstrand, Lilian H.J. Richter
Publikováno v:
Drug testing and analysis. 11(1)
Multiple new psychoactive substances (NPS) are released into the recreational drug market each year. One NPS drug class that has become more common in recent years is that of the benzodiazepines (designer benzodiazepines, DBZ). Several metabolism stu
Publikováno v:
Drug testing and analysis. 10(3)
Over the past ~8 years, hundreds of unregulated new psychoactive substances (NPS) of various chemical categories have been introduced as recreational drugs through mainly open online trade. This study was performed to further investigate the human me
Publikováno v:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 1035
New psychoactive substances (NPS) have become an increasing drug problem in the past decade. For detection of NPS, new analytical methods have to be developed, and the methods also have to be updated regularly. This study aimed at developing a multi-
Publikováno v:
Drug testing and analysis. 9(4)
The emerging new psychoactive substances made available for recreational drug use have recently started to include designer benzodiazepines. As a consequence, the routine immunoassay drug testing for benzodiazepines may become less effective, due to
Publikováno v:
Analytical and bioanalytical chemistry. 408(13)
Among the new psychoactive substances (NPS), so-called designer benzodiazepines have become of particular importance over the last 2 years, due to their increasing availability on the internet drug market. Therapeutically used nitrobenzodiazepines su